• May 28, 2023

Modern Booster Updated Against Omicron: What We Should Expect

Excellent preliminary results from Moderna’s phase 2/3 trial for an updated booster vaccine are coming from the United States. The new mRNA1273-214 vaccine is a bivalent version of the old Moderna vaccine coupled with the new booster built on the Omicron variant. We have learned that viral circulation results in the accumulation of mutations and…

Read More

Covid, those with a food allergy are better protected

From the beginning of the Covid19 pandemic, we immediately realized that some subjects were more severely affected by the disease than others. A parameter that correlates with the severity of the disease is age, in fact we know that the lethality rate doubles every 5 years and therefore the older subjects are those most at…

Read More